Exponent Increases Share Repurchase Authorization by $150 Million

Rhea-AI Summary

Exponent, Inc. (Nasdaq: EXPO) announced a $150 million expansion of its share repurchase program, increasing total available repurchases to approximately $179.5 million. The firm has repurchased $38.9 million of common stock in fiscal year 2022. CEO Dr. Catherine Corrigan expressed confidence in Exponent’s strategic direction and commitment to delivering shareholder value, noting a recent 20% increase in the quarterly dividend. Exponent ended fiscal 2021 with $297.7 million in cash and cash equivalents, supporting its robust capital allocation strategy.

Positive

• Expansion of share repurchase program by $150 million, enhancing shareholder value.
• Total repurchase capacity now stands at approximately $179.5 million.
• Recent 20% increase in quarterly dividend reflects strong financial health.
• Consistent cash flow with $297.7 million in cash and cash equivalents at fiscal year-end.

Negative

• None.

MENLO PARK, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors approved a $150 million expansion of its share repurchase program, adding to the $29.5 million that remains available under the current authorization for repurchases. In total, the Company now has approximately $179.5 million available to repurchase shares. The Company has repurchased $38.9 million of common stock in fiscal year 2022.

“Today’s announcement, combined with the recent 20% increase in our quarterly dividend, reflects our unwavering confidence in Exponent’s strategic direction and our commitment to delivering long-term value for our shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “Exponent’s balanced capital allocation strategy includes investing in initiatives to drive long-term profitable growth while also returning cash to shareholders through dividends and repurchases. This is supported by our consistent cash flow and strong financial position, including that we ended fiscal 2021 with $297.7 million in cash and cash equivalents.”

This plan authorizes Exponent to purchase its common stock in the open market or privately negotiated transactions in compliance with the Securities and Exchange Commission’s Rule 10b-18.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent’s interdisciplinary organization of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 50 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges of sustainability.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the COVID-19 pandemic (including factors relating to measures implemented by governmental authorities or by us to promote the safety of our employees, vendors and clients; other direct and indirect impacts on our business and the businesses of our clients, vendors and other partners; impacts which may, among other things, adversely affect our clients’ ability to utilize our services at the levels they have previously; disruptions of access to our facilities or those of our clients or third parties; and increased and potentially significant economic uncertainty and volatility, including credit and collectability risks and potential disruptions of capital and credit markets), the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.